News Releases

2018 2017 2016 2015 2014 2013
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
October 1, 2018
Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
September 12, 2018
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
September 4, 2018
Zenith Capital Closes $5.7 Million Private Placement
August 31, 2018
Zenith Announces Further Advancement of Clinical Trial with ZEN-3694, a Proposed Equity Offering and an Update Webcast
June 4, 2018

Corporate

Programs

Newsroom

Careers

© 2018 Zenith Epigenetics Ltd. | Legal

Bookmark and Share